Immunomodulatory properties of a new hypoxantine derivative, PCF-39: I. Activation of mature phagocytes and modulation of NK cells

M. Ponzoni, A. Melodia, C. Cirillo, L. S. Perezzani, G. Migliorati, C. Riccardi, G. Forni, P. Cornaglia-Ferraris

Research output: Contribution to journalArticlepeer-review

Abstract

The synthesis of the hypoxanthine derivative Nα-5 (1.6-dihidro-6-oxo-9-purinyl)pentyloxy/carbonyl-L-Arginine, PCF-39 is briefly described. In vitro, results herein presented indicate that PCF-39 modulates the phagocytic cells while being unable to induce terminal differentiation of human leukemic cells, U-937 and HL-60. The NK-activity is also down modulated in mice depending upon age and doses, while NK precursors growth appears to be faster and higher in BM transplanted animals. Data herein presented would confirm what has been previously postulated in immunosuppressed mice treated with PCF-39 before challenging it in several microbial and tumor graft models. Results would indicate that PCF-39 is an interesting synthetic immunomodifier in the family on the hypoxanthine derivatives endowed with immunomodulatory properties.

Original languageEnglish
Pages (from-to)161-165
Number of pages5
JournalEOS Rivista di Immunologia ed Immunofarmacologia
Volume7
Issue number4
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Fingerprint Dive into the research topics of 'Immunomodulatory properties of a new hypoxantine derivative, PCF-39: I. Activation of mature phagocytes and modulation of NK cells'. Together they form a unique fingerprint.

Cite this